Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung

Fig. 6

The biodistribution of PEGylated-GNPs in healthy mice through i.t. administration. a A diagram of the fabrication process of two types of PEGylated-GNPs. b The distribution of different PEGylated-GNPs in the lung, liver, spleen and blood. N = 5 per group, ns: not significant, *p < 0.05, ** p < 0.01

Back to article page